BioPharma Credit PLC USDLSE: BPCP

BioPharma Credit PLC USD: Director/PDMR Shareholding

· Issued by BioPharma Credit PLC USD via RNS

Summary by 6ix AI

Graeme Proudfoot, a director of BioPharma Credit PLC, bought 70,000 ordinary shares in the company at $0.988 each on September 29, 2026, on the London Stock Exchange.

Key details

  • The shares are ordinary shares of $0.01 each.
  • This is an initial notification of a share dealing by a person discharging managerial responsibilities, meaning a director or senior manager.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/directorpdmr-shareholding-1631

BIOPHARMA CREDIT PLC

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Graeme Proudfoot

2.

Reason for the notification

a)

Position / status

Director of BioPharma Credit PLC

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of $0.01 each

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$0.988

70,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

29.09.2026

f)

Place of the transaction

London Stock Exchange (XLON)

BioPharma Credit PLC USD on 6ix

Later from BioPharma Credit PLC USD

All BioPharma Credit PLC USD news releases